Cyclacel Pharmaceuticals Inc (CYCC)
2.27
+0.44
(+24.04%)
USD |
NASDAQ |
Apr 24, 16:00
2.68
+0.41
(+18.06%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Cash from Investing (TTM): -0.006M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.006M |
September 30, 2023 | -0.006M |
June 30, 2023 | -0.006M |
March 31, 2023 | -0.009M |
December 31, 2022 | -0.007M |
September 30, 2022 | -0.009M |
June 30, 2022 | -0.018M |
March 31, 2022 | 0.047M |
December 31, 2021 | -0.027M |
September 30, 2021 | -0.067M |
June 30, 2021 | -0.108M |
March 31, 2021 | -0.17M |
December 31, 2020 | -0.096M |
September 30, 2020 | -0.048M |
June 30, 2020 | -0.002M |
March 31, 2020 | -0.003M |
December 31, 2019 | 0.028M |
September 30, 2019 | 0.016M |
June 30, 2019 | 0.018M |
March 31, 2019 | 0.01M |
December 31, 2018 | -0.039M |
September 30, 2018 | -0.035M |
June 30, 2018 | -0.042M |
March 31, 2018 | -0.033M |
December 31, 2017 | -0.013M |
Date | Value |
---|---|
September 30, 2017 | -0.002M |
June 30, 2017 | 0.007M |
March 31, 2017 | 0.007M |
December 31, 2016 | 0.009M |
September 30, 2016 | 0.071M |
June 30, 2016 | 0.061M |
March 31, 2016 | 0.053M |
December 31, 2015 | 0.062M |
September 30, 2015 | 0.08M |
June 30, 2015 | -0.051M |
March 31, 2015 | 0.019M |
December 31, 2014 | 0.075M |
September 30, 2014 | 0.009M |
June 30, 2014 | 0.143M |
March 31, 2014 | 5.713M |
December 31, 2013 | 5.688M |
September 30, 2013 | 5.665M |
June 30, 2013 | 5.67M |
March 31, 2013 | 0.075M |
December 31, 2012 | 0.05M |
September 30, 2012 | 0.055M |
June 30, 2012 | 0.051M |
March 31, 2012 | 0.014M |
December 31, 2011 | -0.001M |
September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.17M
Minimum
Mar 2021
0.047M
Maximum
Mar 2022
-0.0249M
Average
-0.007M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Corvus Pharmaceuticals Inc | 15.54M |
Oragenics Inc | -0.9363M |
Relmada Therapeutics Inc | 50.45M |
Alpine Immune Sciences Inc | -55.56M |
MAIA Biotechnology Inc | -- |